Alliancebernstein L.P. Edwards Lifesciences Corp Transaction History

Alliancebernstein L.P.

$275 Billion
Q1 2024

A detailed history of Alliancebernstein L.P. transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Alliancebernstein L.P. holds 16,405,731 shares of EW stock, worth $1.52 Billion. This represents 0.57% of its overall portfolio holdings.

Number of Shares

16,405,731

Previous 19,088,643 14.06%

Holding current value

$1.52 Billion

Previous $1.46 Billion 7.71%

% of portfolio

0.57%

Previous 0.57%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$72.54 - $95.56 $195 Million - $256 Million	-2,682,912 Reduced 14.06%	16,405,731 $1.57 Billion
Q4 2023 Feb 14, 2024	SELL	$61.71 - $77.76 $225 Million - $284 Million	-3,653,069 Reduced 16.06%	19,088,643 $1.46 Billion
Q3 2023 Nov 14, 2023	BUY	$69.28 - $93.38 $154 Million - $208 Million	2,229,477 Added 10.87%	22,741,712 $1.58 Billion
Q2 2023 Aug 15, 2023	BUY	$81.41 - $94.33 $5.44 Million - $6.3 Million	66,763 Added 0.33%	20,512,235 $1.93 Billion
Q1 2023 May 15, 2023	SELL	$74.26 - $84.51 $106 Million - $121 Million	-1,428,808 Reduced 6.53%	20,445,472 $1.69 Billion

Q4 2022 Feb 14, 2023	BUY	$68.3 - $87.44 $322 Million - $412 Million	4,712,819 Added 27.46%	21,874,280 $1.63 Billion
Q3 2022 Nov 15, 2022	BUY	$82.37 - $107.29 $65.8 Million - $85.8 Million	799,376 Added 4.89%	17,161,461 $1.42 Billion
Q2 2022 Aug 15, 2022	BUY	$86.5 - $128.27 $198 Million - $293 Million	2,283,544 Added 16.22%	16,362,085 $1.56 Billion
Q1 2022 May 13, 2022	BUY	$101.96 - $128.34 $69.3 Million - $87.3 Million	680,021 Added 5.08%	14,078,541 $1.66 Billion
Q4 2021 Feb 14, 2022	BUY	$106.37 - $130.68 $62 Million - $76.2 Million	583,209 Added 4.55%	13,398,520 $1.74 Billion
Q3 2021 Nov 10, 2021	SELL	$102.91 - $122.75 $20.5 Million - $24.5 Million	-199,542 Reduced 1.53%	12,815,311 $1.45 Billion
Q2 2021 Jul 30, 2021	SELL	$83.84 - $104.76 $5.16 Million - $6.45 Million	-61,530 Reduced 0.47%	13,014,853 $1.35 Billion
Q1 2021 May 06, 2021	BUY	$78.68 - $90.67 $18.9 Million - $21.7 Million	239,765 Added 1.87%	13,076,383 $1.09 Billion
Q4 2020 Feb 08, 2021	SELL	$71.69 - $91.23 $87.3 Million - $111 Million	-1,218,037 Reduced 8.67%	12,836,618 $1.17 Billion
Q3 2020 Nov 12, 2020	BUY	$67.19 - $87.44 $30 Million - $39 Million	446,225 Added 3.28%	14,054,655 $1.12 Billion
Q2 2020 Aug 13, 2020	BUY	$57.54 - $76.95 $535 Million - $715 Million	9,292,643 Added 215.32%	13,608,430 $940 Million
Q1 2020 May 14, 2020	BUY	$52.41 - $81.0 $43.1 Million - $66.6 Million	822,551 Added 23.55%	4,315,787 $814 Million
Q4 2019 Feb 18, 2020	SELL	$71.7 - $82.09 $36 Million - $41.3 Million	-502,741 Reduced 12.58%	3,493,236 $815 Million
Q3 2019 Nov 14, 2019	SELL	$61.55 - $75.43 $22.6 Million - $27.7 Million	-367,756 Reduced 8.43%	3,995,977 $879 Million
Q2 2019 Aug 14, 2019	BUY	$55.74 - $64.41 $4 Million - $4.63 Million	71,811 Added 1.67%	4,363,733 $806 Million
Q1 2019 May 14, 2019	SELL	$47.89 - $64.05 $27.1 Million - $36.3 Million	-566,214 Reduced 11.65%	4,291,922 $821 Million
Q4 2018 Feb 13, 2019	BUY	$46.41 - $56.94 $6.72 Million - $8.25 Million	144,807 Added 3.07%	4,858,136 $744 Million
Q3 2018 Nov 08, 2018	SELL	$45.7 - $58.03 $4.49 Million - $5.7 Million	-98,201 Reduced 2.04%	4,713,329 $821 Million
Q2 2018 Aug 13, 2018	SELL	$42.45 - $51.3 $6.23 Million - $7.52 Million	-146,664 Reduced 2.96%	4,811,530 $700 Million
Q1 2018 May 14, 2018	SELL	$37.19 - $47.45 $48.4 Million - $61.8 Million	-1,301,577 Reduced 20.79%	4,958,194 $692 Million
Q4 2017 Feb 13, 2018	BUY	$33.79 - $39.39 $22.8 Million - $26.6 Million	675,216 Added 12.09%	6,259,771 $706 Million
Q3 2017 Nov 13, 2017	BUY	$36.29 - $38.83 $203 Million - $217 Million	5,584,555	5,584,555 $610 Million

Others Institutions Holding EW

# of Institutions

1,375

Shares Held

454M

Call Options Held

3.86M

Put Options Held

3.32M

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $57.1B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

News

Stay updated on Alliancebernstein L.P. with notifications on news.

Account

Alliancebernstein L.P. Edwards Lifesciences Corp Transaction History